<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04393857</url>
  </required_header>
  <id_info>
    <org_study_id>Microbiome_endometrial_spain</org_study_id>
    <nct_id>NCT04393857</nct_id>
  </id_info>
  <brief_title>The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors</brief_title>
  <official_title>The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peter Humaidan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Bernabeu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Regionshospitalet Viborg, Skive</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to examine the endometrium with state of the art sequencing techniques
      to investigate the endometrial microbiota. The endometrial microbiota has been perceived to
      be sterile, however, this seems incorrect from recent studies. Thus, the primary outcome is
      to compare the rate of ascending infection from the vagina to the endometrium and to
      investigate which bacteria are capable of inhabiting these environments in healthy oocyte
      donors. These results will be compared to equivalent samples of IVF patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 15, 2020</start_date>
  <completion_date type="Anticipated">August 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of ascending infection/sharing of bacteria in the genital tract</measure>
    <time_frame>This outcome data is measured at the 1 day of oocyte retrieval.</time_frame>
    <description>vaginal, cervical and endometrial samples will be compared at the time of oocyte retrieval.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Next generation sequencing techniques and qPCR will be used to assess the microbiota.I.e. measure of relative abundances and absolute abundances</measure>
    <time_frame>This outcome data is measured at the 1 day of oocyte retrieval.</time_frame>
    <description>qPCR to assess the microbiota. I.e. a quantitative measure Copies/mL. 16S V4 to investigate relative abundances</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Bacterial Vaginoses</condition>
  <arm_group>
    <arm_group_label>Oocyte donors</arm_group_label>
    <description>Healthy Oocyte donors fulfilling the criteria for oocyte donation are eligible. Patients may not have received any antibiotics or vaginal products (other than for menstrual hygiene - such as tampons) for the last 1 month. Informed consent is mandatory.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Vaginal, Cervical and endometrial samples taken with the Eswab (Copan), eNAT (Copan) and Tao
      brush (Cook medical). Although there will be Human DNA in samples, we aim to isolate
      bacterial DNA for further analysis. No analyses are planned on Human DNA.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy oocyte donors
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Oocyte donors meeting local criteria for donation. Written informed consent. Regular cycle

        Exclusion Criteria:

        Antibiotics within 1 month Vaginal products other than for menstrual hygiene within 1 month
        Uterine malformations(Septum, polyps, adenomyosis, fibroids) HIV, Hepatitis B or C
        positivity. HPV CIN 2 or higher. Chlamydia trachomatis positivity.

        Any uncontrolled concomitant disease (e.g. uncontrolled diabetes, uncontrolled hypertension
        etc.)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andrea Bernabeu, MD</last_name>
    <phone>+34 965 50 40 00</phone>
    <email>info@institutobernabeu.com</email>
  </overall_contact>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 14, 2020</study_first_submitted>
  <study_first_submitted_qc>May 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2020</study_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Regionshospitalet Viborg, Skive</investigator_affiliation>
    <investigator_full_name>Peter Humaidan</investigator_full_name>
    <investigator_title>Professor, Consultant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginosis, Bacterial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>WE plan to share all information allowed as per national law.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

